Kids v Cancer launches Compassionate Use Navigator tools

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

KIDS V CANCER launched the Compassionate Use Navigator for the pediatric oncology community that provides up-to-date information on the compassionate use application process.

The Compassionate Use Navigator provides: an option for physicians to request help from Compassionate Use Navigator staff in completing a compassionate use application; step-by-step instructions on how to apply for compassionate use, including forms and templates; assistance in identifying points of contact at drug companies; and information on FDA and IRB rules for obtaining compassionate use medications.

In addition, the navigator aims to fill knowledge gaps about compassionate use by collecting data on the numbers and outcomes of applications. This data will lay the groundwork for developing next steps to improve access to drugs for those in dire need.

Table of Contents

YOU MAY BE INTERESTED IN

Cell and gene therapies have made incredible strides over the past decade. The 2024 FDA approvals of the first T-cell receptor therapy for the treatment of metastatic synovial sarcoma and the first tumor-infiltrating lymphocyte therapy for the treatment of unresectable or metastatic melanoma mark a significant turning point for solid tumor treatment.xxx:more
The intersection of diabetes, obesity and cancer represents an important and underappreciated challenge in medicine. Apart from smoking, overweight is now the leading modifiable risk factor for cancer. With the global epidemic of overweight and diabetes driving cancer incidence across multiple organ sites, understanding the metabolic underpinnings of this relationship has never been more critical.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login